Extracellular signal-regulated kinase 2 (ERK-2) mediated phosphorylation regulates nucleo-cytoplasmic shuttling and cell growth control of Ras-associated tumor suppressor protein, RASSF2

Experimental Cell Research

Volumn 315, Issue 16, 2009, Pages 2775-2790

  Kumari, Gita ^a   Mahalingam, S ^a,b  

^a CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

Author keywords

Apoptosis; Cell cycle control; MAPK ERK 2; Nucleo cytoplasmic transport; Phosphorylation; RASSF2

Indexed keywords

AMINO ACID; EXPORTIN 1; ISOLEUCINE; LEPTOMYCIN B; LEUCINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MUTANT PROTEIN; PROTEIN RASSF2; RAS PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL COMPARTMENTALIZATION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL GROWTH; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; NONHUMAN; NUCLEAR EXPORT SIGNAL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 68949150782     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.06.013     Document Type: Article

References (45)

1. Vos M.D., Ellis C.A., Elam C., Ulku A.S., Taylor B.J., and Clark G.J. RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor. J. Biol. Chem. 278 (2003) 28045-28051
2. Eckfeld K., Hesson L., Vos M.D., Bieche I., Latif F., and Clark G.J. RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family. Cancer Res. 64 (2004) 8688-8693
3. Agathanggelou A., Cooper W.N., and Latif F. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res. 65 (2005) 3497-3508
4. Baksh S., Tommasi S., Fenton S., Yu V.C., Martins L.M., Pfeifer G.P., Latif F., Downward J., and Neel B.G. The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death. Mol. Cell 18 (2005) 637-650
5. Song M.S., Song S.J., Ayad N.G., Chang J.S., Lee J.H., Hong H.K., Lee H., Choi N., Kim J., Kim H., Kim J.W., Choi E.J., Kirschner M.W., and Lim D.S. The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat. Cell Biol. 6 (2004) 129-137
6. Rong R., Jin W., Zhang J., Sheikh M.S., and Huang Y. Tumor suppressor RASSF1A is a microtubule-binding protein that stabilizes microtubules and induces G2/M arrest. Oncogene 23 (2004) 8216-8230
7. Agathanggelou A., Dallol A., Zochbauer-Muller S., Morrissey C., Honorio S., Hesson L., Martinsson T., Fong K.M., Kuo M.J., Yuen P.W., Maher E.R., Minna J.D., and Latif F. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Oncogene 22 (2003) 1580-1588
8. Endoh M., Tamura G., Honda T., Homma N., Terashima M., Nishizuka S., and Motoyama T. RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer. Br. J. Cancer 93 (2005) 1395-1399
9. Hesson L., Dallol A., Minna J.D., Maher E.R., and Latif F. NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers. Oncogene 22 (2003) 947-954
10. Harada K., Toyooka S., Maitra A., Maruyama R., Toyooka K.O., Timmons C.F., Tomlinson G.E., Mastrangelo D., Hay R.J., Minna J.D., and Gazdar A.F. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Oncogene 21 (2002) 4345-4349
11. Chestukhin A., Litovchick L., Rudich K., and DeCaprio J.A. Nucleocytoplasmic shuttling of p130/RBL2: novel regulatory mechanism. Mol. Cell. Biol. 22 (2002) 453-468
12. Fabbro M., and Henderson B.R. Regulation of tumor suppressors by nuclear-cytoplasmic shuttling. Exp. Cell Res. 282 (2003) 59-69
13. O Brate A., and Giannakakou P. The importance of p53 location: nuclear or cytoplasmic zip code?. Drug Resist. Updat. 6 (2003) 313-322
14. Kallstrom H., Lindqvist A., Pospisil V., Lundgren A., and Rosenthal C.K. Cdc25A localisation and shuttling: characterisation of sequences mediating nuclear export and import. Exp. Cell Res. 303 (2005) 89-100
15. Yang J., Song H., Walsh S., Bardes E.S., and Kornbluth S. Combinatorial control of cyclin B1 nuclear trafficking through phosphorylation at multiple sites. J. Biol. Chem. 276 (2001) 3604-3609
16. Woods D.B., and Vousden K.H. Regulation of p53 function. Exp. Cell Res. 264 (2001) 56-66
17. Graves P.R., Lovly C.M., Uy G.L., and Piwnica-Worms H. Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding. Oncogene 20 (2001) 1839-1851
18. Lo M.C., Gay F., Odom R., Shi Y., and Lin R. Phosphorylation by the beta-catenin/MAPK complex promotes 14-3-3-mediated nuclear export of TCF/POP-1 in signal-responsive cells in C. elegans. Cell 117 (2004) 95-106
19. Nakielny S., and Dreyfuss G. Transport of proteins and RNAs in and out of the nucleus. Cell 99 (1999) 677-690
20. Corbett A.H., and Silver P.A. Nucleocytoplasmic transport of macromolecules. Microbiol. Mol. Biol. Rev. 61 (1997) 193-211
21. Gorlich D., and Mattaj I.W. Nucleocytoplasmic transport. Science 271 (1996) 1513-1518
22. Dingwall C., and Laskey R.A. Nuclear targeting sequences-a consensus?. Trends Biochem. Sci. 16 (1991) 478-481
23. Kudo N., Matsumori N., Taoka H., Fujiwara D., Schreiner E.P., Wolff B., Yoshida M., and Horinouchi S. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 9112-9117
24. Hutten S., and Kehlenbach R.H. CRM1-mediated nuclear export: to the pore and beyond. Trends Cell Biol. 17 (2007) 193-201
25. Fuerst T.R., Earl P.L., and Moss B. Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Mol. Cell. Biol. 7 (1987) 2538-2544
26. Mahalingam S., Van Tine B., Santiago M.L., Gao F., Shaw G.M., and Hahn B.H. Functional analysis of the simian immunodeficiency virus Vpx protein: identification of packaging determinants and a novel nuclear targeting domain. J. Virol. 75 (2001) 362-374
27. Kumari G., Singhal P.K., Rao M.R., and Mahalingam S. Nuclear transport of Ras-associated tumor suppressor proteins: different transport receptor binding specificities for arginine-rich nuclear targeting signals. J. Mol. Biol. 367 (2007) 1294-1311
28. Roth J., Dobbelstein M., Freedman D.A., Shenk T., and Levine A.J. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17 (1998) 554-564
29. Xiao Z., Brownawell A.M., Macara I.G., and Lodish H.F. A novel nuclear export signal in Smad1 is essential for its signaling activity. J. Biol. Chem. 278 (2003) 34245-34252
30. Ishida N., Hara T., Kamura T., Yoshida M., Nakayama K., and Nakayama K.I. Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J. Biol. Chem. 277 (2002) 14355-14358
31. Bean L.J., and Stark G.R. Regulation of the accumulation and function of p53 by phosphorylation of two residues within the domain that binds to Mdm2. J. Biol. Chem. 277 (2002) 1864-1871
32. Addinall S.G., Mayr P.S., Doyle S., Sheehan J.K., Woodman P.G., and Allan V.J. Phosphorylation by cdc2-CyclinB1 kinase releases cytoplasmic dynein from membranes. J. Biol. Chem. 276 (2001) 15939-15944
33. Assefa Z., Vantieghem A., Declercq W., Vandenabeele P., Vandenheede J.R., Merlevede W., de Witte P., and Agostinis P. The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin. J. Biol. Chem. 274 (1999) 8788-8796
34. Fatica A., and Tollervey D. Making ribosomes. Curr. Opin. Cell Biol. 14 (2002) 313-318
35. Olson M.O., Hingorani K., and Szebeni A. Conventional and nonconventional roles of the nucleolus. Int. Rev. Cytol. 219 (2002) 199-266
36. Bernardi R., and Pandolfi P.P. The nucleolus: at the stem of immortality. Nat. Med. 9 (2003) 24-25
37. Ruggero D., and Pandolfi P.P. Does the ribosome translate cancer?. Nat. Rev., Cancer 3 (2003) 179-192
38. Llanos S., Clark P.A., Rowe J., and Peters G. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. Nat. Cell Biol. 3 (2001) 445-452
39. Lee C., Smith B.A., Bandyopadhyay K., and Gjerset R.A. DNA damage disrupts the p14ARF-B23(nucleophosmin) interaction and triggers a transient subnuclear redistribution of p14ARF. Cancer Res. 65 (2005) 9834-9842
40. Pines J., and Hunter T. The differential localization of human cyclins A and B is due to a cytoplasmic retention signal in cyclin B. EMBO J. 13 (1994) 3772-3781
41. Mailand N., Podtelejnikov A.V., Groth A., Mann M., Bartek J., and Lukas J. Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO J. 21 (2002) 5911-5920
42. Lefloch R., Pouyssegur J., and Lenormand P. Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels. Mol. Cell. Biol. 28 (2008) 511-527
43. Jans D.A., Ackermann M.J., Bischoff J.R., Beach D.H., and Peters R. p34cdc2-mediated phosphorylation at T124 inhibits nuclear import of SV-40 T antigen proteins. J. Cell Biol. 115 (1991) 1203-1212
44. Zhang F., White R.L., and Neufeld K.L. Phosphorylation near nuclear localization signal regulates nuclear import of adenomatous polyposis coli protein. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 12577-12582
45. Liku M.E., Nguyen V.Q., Rosales A.W., Irie K., and Li J.J. CDK phosphorylation of a novel NLS-NES module distributed between two subunits of the Mcm2-7 complex prevents chromosomal rereplication. Mol. Biol. Cell 16 (2005) 5026-5039